Literature DB >> 16204272

Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.

Benedita Sampaio-Maia1, Mónica Moreira-Rodrigues, Paula Serrão, Manuel Pestana.   

Abstract

BACKGROUND: A primary tubular sodium handling abnormality has been implicated in the edema formation of nephrotic syndrome. Dopamine synthesized by renal proximal tubules behaves as an endogenous natriuretic hormone by activating D(1)-like receptors as a paracrine/autocrine substance.
METHODS: We examined the time courses of the urinary excretion of sodium, protein and dopamine in puromycin aminonucleoside (PAN)-treated and control rats. The rats were sacrificed during greatest sodium retention (day 7) as well as during negative sodium balance (day 14) for the evaluation of renal aromatic l-amino acid decarboxylase (AADC) activity, the enzyme responsible for the synthesis of renal dopamine. Also, the influence of volume expansion (VE) and the effects of the D(1)-like agonist fenoldopam (10 microg/kg bw/min) on natriuresis and on proximal tubular Na(+),K(+)-ATPase activity were examined on day 7.
RESULTS: The daily urinary excretion of dopamine was decreased in PAN-treated rats, from day 5 and beyond. This was accompanied by a marked decrease in the renal AADC activity, on days 7 and 14. During VE, the fenoldopam-induced decrease in proximal tubular Na(+),K(+)-ATPase activity was more pronounced in PAN-treated rats than in controls. However, the urinary sodium excretion during fenoldopam infusion was markedly increased in control rats but was not altered in PAN-treated animals.
CONCLUSION: PAN nephrosis is associated with a blunted renal dopaminergic system activity which may contribute to enhance the proximal tubular Na(+),K(+)-ATPase activity. However, the lack of renal dopamine appears not to be related with the overall renal sodium retention in a state of proteinuria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204272     DOI: 10.1093/ndt/gfi171

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

Review 1.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

Review 2.  The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio A Brito-Melo; Cayo Antônio Soares de Almeida; Lázaro Lopes Moreira; Cleiton Willian Cordeiro; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

3.  Concerted action of ANP and dopamine D1-receptor to regulate sodium homeostasis in nephrotic syndrome.

Authors:  Cátia Fernandes-Cerqueira; Benedita Sampaio-Maia; Janete Quelhas-Santos; Mónica Moreira-Rodrigues; Liliana Simões-Silva; Ana M Blazquez-Medela; C Martinez-Salgado; Jose M Lopez-Novoa; Manuel Pestana
Journal:  Biomed Res Int       Date:  2013-07-15       Impact factor: 3.411

4.  Dopamine regulates renal osmoregulation during hyposaline stress via DRD1 in the spotted scat (Scatophagus argus).

Authors:  Maoliang Su; Xingjiang Mu; Lang Gui; Peipei Zhang; Jianan Zhou; Jie Ma; Junbin Zhang
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

Review 5.  Atrial natriuretic peptide and renal dopaminergic system: a positive friendly relationship?

Authors:  Marcelo Roberto Choi; Natalia Lucía Rukavina Mikusic; Nicolás Martín Kouyoumdzian; María Cecilia Kravetz; Belisario Enrique Fernández
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

6.  Calcitriol Prevents Cardiovascular Repercussions in Puromycin Aminonucleoside-Induced Nephrotic Syndrome.

Authors:  Fernandes-Cerqueira Cátia; Quelhas-Santos Janete; Sampaio-Maia Benedita; Simões-Silva Liliana; Soares-Silva Isabel; Roncon-Albuquerque Roberto; Pestana Manuel
Journal:  Biomed Res Int       Date:  2018-01-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.